Output and aerosol properties of 5 nebulizer/compressor systems with arformoterol inhalation solution

Respiratory Care

Volumn 54, Issue 10, 2009, Pages 1342-1347

  Bauer, Andrea ^a   McGlynn, Paul ^a   Bovet, Li Li ^b   Mims, Pamela L ^b   Curry, Lisa A ^a   Hanrahan, John P ^c  

^a Sepracor   (United States)

^b Cirrus Pharmaceuticals   (United States)

^c PULMATRIX INC   (United States)

Author keywords

Aerosol; Andersen cascade impactor; Arformoterol; Compressor; Delivered dose; Droplet size distribution; Laser diffraction; Nebulizer

Indexed keywords

ARFORMOTEROL;

AEROSOL; ARTICLE; COMPRESSOR; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FLOW RATE; MEDICAL INSTRUMENTATION; MEDICAL NEBULIZER; PARTICLE SIZE;

AEROSOLS; BRONCHODILATOR AGENTS; ETHANOLAMINES; HUMANS; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE;

EID: 70349923912     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23(6):932-946. (Pubitemid 38807371)
2. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176(6):532-555. (Pubitemid 47403272)
3. Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, et al. Device selection and outcomes of aerosol therapy: evidencebased guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005;127(1):335-371. (Pubitemid 41724594)
4. Baumgartner RA, Hanania NA, Calhoun WJ, Sahn SA, Sciarappa K, Hanrahan JP. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo-and active-controlled trial. Clin Ther 2007;29(2):261-278. (Pubitemid 46671382)
5. Hanrahan J, Hanania NA, Calhoun WJ. Sahn SA, Sciarappa K, Baumgartner RA. Effect of nebulized arformoterol on airway function in COPD: results from two randomized trials. COPD 2008;5(1):25-34. (Pubitemid 351225522)
6. Kendrick AH, Smith EC, Wilson RS. Selecting and using nebuliser equipment. Thorax 1997;52(Suppl 2):S92-S101.
7. Smaldone GC, Cruz-Rivera M, Nikander K. In vitro determination of inhaled mass and particle distribution for budesonide nebulizing suspension. J Aerosol Med 1998;11(2):113-125.
8. Newnham DM, Lipworth BJ. Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ("Ventstream"). Thorax 1994;49(8):762-770.
9. Rau JL, Ari A, Restrepo RD. Performance comparison of nebulizer designs: constant-output, breath-enhanced, and dosimetric. Respir Care 2004;49(2):174-179.
10. Dennis JH. A review of issues relating to nebulizer standards. J Aerosol Med 1998;11(Suppl 1):S73-S79.
11. Coates AL, MacNeish CF, Lands LC, Meisner D, Kelemen S, Vadas EB. A comparison of the availability of tobramycin for inhalation from vented vs unvented nebulizers. Chest 1998;113(4):951-956. (Pubitemid 28216437)
12. Smaldone GC. Drug delivery via aerosol systems: concept of "aerosol inhaled". J Aerosol Med 1991;4(3):229-235.
13. Smaldone GC, Fuhrer J, Steigbigel RT, McPeck M. Factors determining pulmonary deposition of aerosolized pentamidine in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1991;143(4 Pt 1):727-737.
14. Chapter 601, Aerosols, nasal sprays, metered-dose inhalers, and drypowder inhalers. United States Pharmacopoeia.
15. Mitchell JP, Nagel MW, Bates SL, Doyle CC. An in vitro study to investigate the use of a breath-actuated, small-volume, pneumatic nebulizer for the delivery of methacholine chloride bronchoprovocation agent. Respir Care 2003;48(1):46-51.
16. Denyer J, Dyche A, Nikander K. Breathing patterns in adult patients (abstract). J Aerosol Med 1997;10(1):99.
17. Bosco AP, Rhem RG, Dolovich MB. In vitro estimations of in vivo jet nebulizer efficiency using actual and simulated tidal breathing patterns. J Aerosol Med 2005;18(4):427-438.
18. Barry PW, O'Callaghan C. An in vitro analysis of the output of budesonide from different nebulizers. J Allergy Clin Immunol 1999;104(6):1168-1173. (Pubitemid 30004975)
19. Ho SL, Kwong WT, O'Drowsky L, Coates AL. Evaluation of four breath-enhanced nebulizers for home use. J Aerosol Med 2001;14(4):467-475. (Pubitemid 34008103)
20. Smith EC, Denyer J, Kendrick AH. Comparison of twenty-three nebulizer/compressor combinations for domiciliary use. Eur Respir J 1995;8(7):1214-1221.